Deterministic biological-state infrastructure for longevity clinics, specialty labs and health platforms

Biology generates data - AXIS creates structure.

AXIS converts fragmented biomarker data into versioned, explainable and longitudinal representations of biological state. The deterministic Blood engine is functional; the architecture is designed to connect blood, fecal microbiota, urine biomarkers and metabolomics, genetics, wearables and phenotypic and contextual data through within-domain patterns and cross-patterns. Multimodal configurations are being developed for bounded partner pilots.

Functional Blood engine · multimodal cross-pattern modules in development · medical pathways governed separately
Multiple biological inputs. One deterministic structure.Blood · fecal microbiota · urine & metabolomics · genetics · wearables · phenotypic and contextual data
AXIS Core Blood · current public configuration
Functional engine
86DBSI / 100
Metabolic regulation
78
Inflammation & innate response
79
O₂ & iron transport
85
Renal & excretory function
100
93%Confidence
90%Weighted signal
95%Coverage
4/4Axes with data

DBSI = Deterministic Biological State Index. An explainable 0–100 episode-level synthesis; higher values indicate lower modeled deviation within the configured AXIS module. It is not a diagnosis.

Sanitized public reconstruction of an output produced by the current deterministic engine. It is not the production interface, does not represent a patient and is not a clinical result.

40 normalized parametersCanonical identity, units, context and source traceability.
27 deterministic patternsExplicit activations with confidence, coverage and coherence.
10 functional blocks · 4 axes · 1 stateCurrent ruleset; 8 blocks are active in the displayed operational run.
US-first commercial entryClinics, specialty labs and health platforms; medical execution remains separate.
01 / Commercial surface

Built for organizations already generating complex biological data.

AXIS adds a governed biological-state layer to the measurements, assays and professional workflows organizations already use.

01 · Provider workflow

Longevity & wellness clinics

Formalize multidisciplinary interpretation, reduce repeated manual synthesis and create a consistent longitudinal view across episodes.

Explore clinics
02 · Lab infrastructure

Specialty laboratories

Add a governed interpretation layer around one panel or a multimodal program, with white-label and integration pathways.

Explore labs
03 · Structured substrate

Health & data platforms

Expose stable, versioned biological-state outputs to products, APIs and downstream analytics without weakening traceability.

Explore the platform
AXIS Core BloodSanitized operational view
Functional engine
Real interface from the current AXIS engine, shown in its present internal language configuration. US-English localization is part of productization. The view is sanitized, contains no patient identifiers and is presented as product evidence—not as a clinical result.
02 / Product evidence

The engine is functional today.

The current AXIS Core Blood environment executes the full deterministic hierarchy and exposes the resulting state, axes, confidence, coverage and version context. Public disclosure remains intentionally limited; deeper traceability is available through qualified access.

Operational executionNormalization through structured biological-state synthesis.
Versioned behaviorSame input + same configuration = same output.
Visible evidence contextAxes, coverage, confidence, conflicts and calculation version.
Protected disclosureNo thresholds, weights, proprietary rules or identifiable data exposed.
03 / Multimodal biological structure

Multiple biological inputs - One deterministic structure.

AXIS is designed to preserve the identity and provenance of each source while relating signals across blood, fecal microbiota, urine biomarkers and metabolomics, genetics, wearables and phenotypic and contextual data.

Biological & contextual input domains
Within-domain patterns What is happening inside each biological layer?

Source-specific signals remain attributable to the measurements and domain that produced them.

Then relate the layers
Cross-pattern architecture How do signals converge, diverge or interact across domains?

Cross-patterns encode explicit, versioned relationships whose contributing evidence comes from two or more input domains.

Structured outputs
BlocksFunctional grouping
AxesHigher-order state
DBSIEpisode synthesis
TrajectoryLongitudinal change
01 / BLOOD

Blood analytics

Blood analytics provide the current functional entry point for the deterministic Core.

Example input

Blood count, glucose regulation, lipids, liver, renal, inflammatory and iron-transport markers, with units, provenance and timing.

Cross-pattern roleA source-specific state that can contribute to governed cross-patterns with other domains as each multimodal module is defined and validated.
Cross-pattern = an explicit, versioned biological relationship supported by evidence from more than one domain.

It can represent convergence, discordance or interaction while preserving the provenance, coverage and confidence of the contributing signals.

A closer structured approximation to biological complexity—without becoming a black box.

AXIS does not claim to reproduce the full complexity of human biology. It provides a more complete and inspectable representation than reviewing blood, microbiota, metabolomics, genetics or wearable reports independently. The multimodal cross-pattern configuration remains in development and requires validation within each defined use case.

04 / Structural gap

The market is not short of measurements - It is short of biological structure.

Existing tests produce valuable data, but their relationships, conflicts and evolution across time often remain manual, inconsistent or opaque.

Fragmented inputs

Blood, fecal microbiota, urine biomarkers and metabolomics, genetics, wearables and context arrive in different formats and interpretive frameworks.

Expertise trapped in people

High-value biological reasoning often lives in clinician memory, local notes or non-versioned workflows.

Repeated snapshots

More testing accumulates, but persistence, direction and response remain weakly structured over time.

Opaque intelligence

Black-box scores make it difficult to inspect evidence, govern changes or progress toward regulated uses.

05 / Deterministic architecture

AI is not the first layer - Structure is.

AXIS creates a governed state layer between biological measurements and the applications built on top of them.

  • Canonical parameters with source, unit and module-specific System Insight Range (SIR).
  • Versioned inference: parameter → pattern → block → axis → DBSI / trajectory.
  • Visible confidence, coverage, coherence and conflict handling.
  • Module separation across wellness, research and future medical uses.
  • ML and LLM layers can consume the state without silently redefining the deterministic Core.
Deterministic state pipeline
Select a stage
01 / INPUT

Data

Biological measurements and authorized context are organized as one governed episode.

Example

Blood markers, fecal microbiota, urine metabolomics, genetics and wearable data collected for the same analysis window.

DeliversSource-linked episode data
06 / Product architecture

One governed engine - Multiple deployable products.

The current engine, internal platform and future commercial surfaces share one deterministic architecture while retaining explicit lifecycle states, intended uses and evidence boundaries.

CORE 01 / FUNCTIONAL

AXIS Core Blood

The deterministic engine executes the governed hierarchy from normalized laboratory parameters to patterns, blocks, four axes and episode synthesis.

Input and output

Input: normalized blood parameters with provenance and version. Output: traceable patterns, blocks, axes, confidence, coverage and DBSI synthesis.

Audience and current stateUsed by the AXIS technical environment and qualified evaluation workflows. Current state: functional end to end; external validation and medical certification remain separate next steps.
07 / Market entry

Commercial entry with independently governed regulatory pathways.

US wellness and laboratory pilots can generate commercial learning while medical modules retain separate evidence, quality and regulatory requirements.

Initial commercial entry

US longevity, wellness and specialty-laboratory partnerships

Bounded pilots, provider-facing reports, white-label programs and progressive integration can test workflow value and commercial demand.

  • One defined program or panel
  • Provider-supervised, non-diagnostic output
  • Retrospective or controlled pilot
  • Clear data and output contracts
Parallel medical execution

European medical pathway

The medical pathway remains independently governed, with its own validation, quality-system and regulatory requirements.

  • Class B IVD route indicated through AEMPS consultation
  • External validation remains outstanding
  • CE marking has not yet been obtained
  • Medical claims remain version- and jurisdiction-specific
08 / Current readiness

Functional today - Explicit about what comes next.

AXIS has moved beyond concept risk, while external evidence, productization, integration and repeatable deployment remain the next value-creation steps.

Functional now

Core Blood engine

Normalization, deterministic hierarchy, confidence, coherence, conflicts, axes, synthesis and traceability.

Pending

External validation

Scientific and clinical performance requires external evaluation under frozen, predefined protocols.

In progress

IP strategy

Patent, trademark, know-how, code and documentation protections are being formalized.

Built to scale

Modular architecture

Medical, research and wellness modules retain separate rules, versions, claims and outputs.

Scientific governance by design

AXIS is being developed around a proposed two-layer institutional architecture: an operating company intended to build, license and scale products and deployments, and a future independent governance layer that may protect the AXIS Charter, deterministic Core principles and scientific standards. The final legal structure is not yet constituted.

Explore scientific governance
09 / Founder & architecture

Clinical depth - Systems thinking - Institutional discipline.

AXIS was conceived to convert fragmented biomedical data into a governed, traceable representation built for professional utility, validation and scale.

Dr Christopher Pack, Founder and Architect of AXIS Framework
Founder & Architect

Dr Christopher Pack

Radiologist · biological-state architecture · deterministic Core governance

Christopher combines clinical practice, structural reasoning and long-term product architecture. Engineering execution and specialist regulatory and IP support extend the founder-led scientific direction.

Clinical architectureCore governanceProduct direction
Qualified pilot model

Start with one defined workflow - not an uncontrolled platform rollout.

The strongest first engagement begins with one program, one user group, one evidence boundary and one output contract.

Discuss a pilot